Submit Your Feeds

Business News • PR NewsWire • Integrated Analysis Demonstrates That Denosumab Delays the Onset of Bone Complications Compared to Zometa®

Integrated Analysis Demonstrates That Denosumab Delays the Onset of Bone Complications Compared to Zometa®
Integrated Analysis Demonstrates That Denosumab Delays the Onset of Bone Complications Compared to Zometa®

THOUSAND OAKS, Calif., Oct. 10 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN) today announced results from two integrated analyses of head-to-head pivotal Phase 3 trials comparing denosumab to Zometa® (zoledronic acid), the current standard of care in the prevention of skeletal related eve

View More : http://www.prnewswire.com/news-releases/integrated-analysis-demonstrates-that-denosumab-delays-the-onset-of-bone-complic...
Releted News by prnewswire
2011 Chevrolet Volt Reinvents Automotive Transportation in a Complete, No-Compromises Electric Package
Middle East Tunnel Megaprojects to be Discussed in Abu Dhabi
Integrated Analysis Demonstrates That Denosumab Delays the Onset of Bone Complications Compared to Zometa®
Global 'Digital Life' Research Project Reveals Major Changes in Online Behaviour
Designing and Constructing Hotels to Meet the Demand of Egypt's Tourism Boom
Rentrak Announces Official Box Office Totals for Weekend of October 8, 2010
Home Sitemap Contact Us
© businessNewsNewsNews.com